Literature DB >> 26366379

Minimally invasive parathyroidectomy with or without intraoperative parathyroid hormone for primary hyperparathyroidism.

Hyun Gu Kim1, Woo Young Kim1, Sang Uk Woo1, Jae Bok Lee1, Yu-Mi Lee2.   

Abstract

PURPOSE: The improvement of intraoperative parathyroid hormone (IOPTH) assay and localization studies has enabled a minimally invasive parathyroidectomy (MIP) in primary hyperparathyroidism (pHPT). The aim of this study is to analyze the demographics, clinical presentations, and surgical outcomes of the pHPT patients who received surgical management with versus without IOPTH.
METHODS: Analysis of a database was performed on 53 patients who underwent parathyroidectomy for pHPT from 2004 to 2013. Preoperative localization was done by both sestamibi scan and ultrasonography. We divided the patients into two groups (without IOPTH versus with IOPTH) and analyzed the surgical outcomes statistically between two groups.
RESULTS: The concordance rate of Technetium 99m sestamibi scan and ultrasonography was 73.6% and 90.6%, respectively. The overall cure rate of group 1 (without IOPTH) was 94.9% and that of group 2 (with IOPTH) was 100%. The decline of PTH at postoperative 5 minutes and 10 minutes was 75.2% ± 14.9% and 84.9% ± 8.6% in cured patients. On the other hand, that of noncured patients at 5 minutes and 10 minutes was 17.2% ± 9.7% and 8.2% ± 2.2%. There was a significant difference in the drop rate of IOPTH between cured and persistent patients (P < 0.01). Pathological examination showed adenoma in 41 of 53 patients (77.4%) and hyperplasia in 10 of 53 patients (18.9%).
CONCLUSION: Even though the localization studies were successful, IOPTH monitoring is essential to avoid a surgical failure in MIP.

Entities:  

Keywords:  Parathyroid hormone; Parathyroidectomy; Primary hyperparathyroidism; Technetium Tc 99m sestamibi; Ultrasonography

Year:  2015        PMID: 26366379      PMCID: PMC4559612          DOI: 10.4174/astr.2015.89.3.111

Source DB:  PubMed          Journal:  Ann Surg Treat Res        ISSN: 2288-6575            Impact factor:   1.859


  29 in total

Review 1.  Primary hyperparathyroidism: pathophysiology and impact on bone.

Authors:  A Khan; J Bilezikian
Journal:  CMAJ       Date:  2000-07-25       Impact factor: 8.262

2.  The superiority of minimally invasive parathyroidectomy based on 1650 consecutive patients with primary hyperparathyroidism.

Authors:  Robert Udelsman; Zhenqiu Lin; Patricia Donovan
Journal:  Ann Surg       Date:  2011-03       Impact factor: 12.969

3.  Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop.

Authors:  John P Bilezikian; Aliya A Khan; John T Potts
Journal:  J Clin Endocrinol Metab       Date:  2009-02       Impact factor: 5.958

4.  What is the link between nonlocalizing sestamibi scans, multigland disease, and persistent hypercalcemia? A study of 401 consecutive patients undergoing parathyroidectomy.

Authors:  Bill Chiu; Cord Sturgeon; Peter Angelos
Journal:  Surgery       Date:  2006-07-27       Impact factor: 3.982

5.  Values of ultrasonography, sestamibi scintigraphy, and intraoperative measurement of 1-84 PTH for unilateral neck exploration of primary hyperparathyroidism.

Authors:  Y Chapuis; Y Fulla; P Bonnichon; E Tarla; B Abboud; J Pitre; B Richard
Journal:  World J Surg       Date:  1996-09       Impact factor: 3.352

6.  Does intraoperative quick parathyroid hormone assay improve the results of parathyroidectomy?

Authors:  Daishu Miura; Nobuyuki Wada; Cumhur Arici; Eugene Morita; Quan-Yang Duh; Orlo H Clark
Journal:  World J Surg       Date:  2002-04-30       Impact factor: 3.352

7.  Minimally invasive parathyroidectomy without intraoperative parathyroid hormone monitoring in patients with primary hyperparathyroidism.

Authors:  R Mihai; F F Palazzo; F V Gleeson; G P Sadler
Journal:  Br J Surg       Date:  2007-01       Impact factor: 6.939

8.  Is minimally invasive parathyroidectomy associated with greater recurrence compared to bilateral exploration? Analysis of more than 1,000 cases.

Authors:  David F Schneider; Haggi Mazeh; Rebecca S Sippel; Herbert Chen
Journal:  Surgery       Date:  2012-10-12       Impact factor: 3.982

9.  Minimally invasive parathyroidectomy using surgeon-performed ultrasound and sestamibi.

Authors:  Subhita Prasannan; Giles Davies; Melissa Bochner; James Kollias; Peter Malycha
Journal:  ANZ J Surg       Date:  2007-09       Impact factor: 1.872

10.  Predictors of accuracy in preoperative parathyroid adenoma localization using ultrasound and Tc-99m-Sestamibi: a 4-quadrant analysis.

Authors:  Cameron D Adkisson; Stephanie L Koonce; Michael G Heckman; Colleen S Thomas; Adam S Harris; John D Casler
Journal:  Am J Otolaryngol       Date:  2013-06-10       Impact factor: 1.808

View more
  5 in total

1.  Comparison of minimally invasive parathyroidectomy under local anaesthesia and minimally invasive video-assisted parathyroidectomy for primary hyperparathyroidism: a cost analysis.

Authors:  G I Melfa; C Raspanti; M Attard; G Cocorullo; A Attard; S Mazzola; G Salamone; G Gulotta; G Scerrino
Journal:  G Chir       Date:  2016 Mar-Apr

2.  Characteristics of patients operated for primary hyperparathyroidism at university hospitals in Türkiye: differences among Türkiye's geographical regions.

Authors:  Turkay Kirdak; Nuh Zafer Canturk; Nusret Korun; Gokhan Ocakoglu
Journal:  Ann Surg Treat Res       Date:  2016-06-30       Impact factor: 1.859

3.  Impact of preoperative imaging on surgical approach for primary hyperparathyroidism: Data from single institution in India.

Authors:  Parjeet Kaur; Raghav Gattani; Alka Ashmita Singhal; Deepak Sarin; Sowrabh Kumar Arora; Ambrish Mithal
Journal:  Indian J Endocrinol Metab       Date:  2016 Sep-Oct

4.  Validation of selective use of intraoperative PTH monitoring in parathyroidectomy.

Authors:  Alexandra Thielmann; Paul Kerr
Journal:  J Otolaryngol Head Neck Surg       Date:  2017-02-06

5.  Is focused parathyroidectomy appropriate for patients with primary hyperparathyroidism?

Authors:  Won Woong Kim; Yumie Rhee; Eun Jeong Ban; Cho Rok Lee; Sang-Wook Kang; Jong Ju Jeong; Kee-Hyun Nam; Woong Youn Chung; Cheong Soo Park
Journal:  Ann Surg Treat Res       Date:  2016-08-29       Impact factor: 1.859

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.